239 related articles for article (PubMed ID: 2554768)
21. Acyclovir-resistant, pathogenic herpesviruses.
Coen DM
Trends Microbiol; 1994 Dec; 2(12):481-5. PubMed ID: 7889324
[TBL] [Abstract][Full Text] [Related]
22. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
[TBL] [Abstract][Full Text] [Related]
23. An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.
Sakuma S; Yamamoto M; Kumano Y; Mori R
Arch Virol; 1988; 101(3-4):169-82. PubMed ID: 2845890
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of acyclovir-resistant strains of herpes simplex virus.
Field HJ; Larder BA; Darby G
Am J Med; 1982 Jul; 73(1A):369-71. PubMed ID: 6285724
[TBL] [Abstract][Full Text] [Related]
25. Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models.
Dambrosi S; Martin M; Yim K; Miles B; Canas J; Sergerie Y; Boivin G
J Med Virol; 2010 May; 82(6):1000-6. PubMed ID: 20419814
[TBL] [Abstract][Full Text] [Related]
26. Properties of purified enzymes induced by pathogenic drug-resistant mutants of herpes simplex virus. Evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase.
Larder BA; Derse D; Cheng YC; Darby G
J Biol Chem; 1983 Feb; 258(3):2027-33. PubMed ID: 6296119
[TBL] [Abstract][Full Text] [Related]
27. Resistance of herpes simplex to acyclovir.
Balfour HH
Ann Intern Med; 1983 Mar; 98(3):404-6. PubMed ID: 6299155
[No Abstract] [Full Text] [Related]
28. [Acyclovir-resistant herpes simplex virus].
Aukrust P
Tidsskr Nor Laegeforen; 1990 Sep; 110(21):2770-3. PubMed ID: 2171155
[TBL] [Abstract][Full Text] [Related]
29. Penciclovir and pathogenesis phenotypes of drug-resistant Herpes simplex virus mutants.
Pelosi E; Mulamba GB; Coen DM
Antiviral Res; 1998 Jan; 37(1):17-28. PubMed ID: 9497069
[TBL] [Abstract][Full Text] [Related]
30. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy.
Sibrack CD; McLaren C; Barry DW
Am J Med; 1982 Jul; 73(1A):372-5. PubMed ID: 6285725
[TBL] [Abstract][Full Text] [Related]
31. Biological and biochemical characterization of clinical isolates of herpes simplex virus type 2 resistant to acyclovir.
Oliver NM; Collins P; Van der Meer J; Van't Wout JW
Antimicrob Agents Chemother; 1989 May; 33(5):635-40. PubMed ID: 2546486
[TBL] [Abstract][Full Text] [Related]
32. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
[TBL] [Abstract][Full Text] [Related]
33. Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child.
Sibrack CD; Gutman LT; Wilfert CM; McLaren C; St Clair MH; Keller PM; Barry DW
J Infect Dis; 1982 Nov; 146(5):673-82. PubMed ID: 6290575
[TBL] [Abstract][Full Text] [Related]
34. Recurrent herpes simplex virus hepatitis after liver retransplantation despite acyclovir therapy.
Longerich T; Eisenbach C; Penzel R; Kremer T; Flechtenmacher C; Helmke B; Encke J; Kraus T; Schirmacher P
Liver Transpl; 2005 Oct; 11(10):1289-94. PubMed ID: 16184558
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
36. A perspective on resistance to acyclovir in herpes simplex virus.
Field HJ
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():129-35. PubMed ID: 6313592
[TBL] [Abstract][Full Text] [Related]
37. A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates.
Palù G; Gerna G; Bevilacqua F; Marcello A
Virus Res; 1992 Sep; 25(1-2):133-44. PubMed ID: 1329374
[TBL] [Abstract][Full Text] [Related]
38. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance.
Darby G; Field HJ; Salisbury SA
Nature; 1981 Jan; 289(5793):81-3. PubMed ID: 6256650
[TBL] [Abstract][Full Text] [Related]
39. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
[TBL] [Abstract][Full Text] [Related]
40. Cooperative effects between two acyclovir resistance loci in herpes simplex virus.
Darby G; Churcher MJ; Larder BA
J Virol; 1984 Jun; 50(3):838-46. PubMed ID: 6328014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
